Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The objective is to compare efficacy and safety of masitinib at 9 mg/kg/day in combination with gemcitabine, to placebo in combination with gemcitabine, in treatment of patients with advanced/metastatic pancreatic cancer.
Critère d'inclusion
- advanced metastatic pancreatic cancer